Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. The company was founded by Mitchell Dann and John M. Reid on May 29, 1991 and is headquartered in Minneapolis, MN.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of 21st North Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. 21st North Inc market cap is $2,200.00.
What is the 52-week high for 21st North Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. 21st North Inc 52 week high is $0.0401 as of October 03, 2025.
What is the 52-week low for 21st North Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. 21st North Inc 52 week low is $0.00 as of October 03, 2025.
What is 21st North Inc stock price today?
21st North Inc stock price today is $0.0001.
What is the 50-day moving average of 21st North Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. 21st North Inc 50-day moving average is $0.0006.